Lizhen Lin - PharmaEngine Director
4162 Stock | TWD 90.70 0.50 0.55% |
Director
Lin Quan was serving as Director in PharmaEngine, Inc. since January 26, 2015. Lin also serves as Director in TTY Biopharm Company Limited. since 2014.
Tenure | 10 years |
Phone | 886 2 2515 8228 |
Web | https://www.pharmaengine.com |
PharmaEngine Management Efficiency
The company has return on total asset (ROA) of 0.0589 % which means that it generated a profit of $0.0589 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0985 %, meaning that it generated $0.0985 on every $100 dollars invested by stockholders. PharmaEngine's management efficiency ratios could be used to measure how well PharmaEngine manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | DIRECTOR Age | ||
Meixiang He | Adimmune Corp | N/A | |
Ruijie Chen | Adimmune Corp | N/A | |
Junhua Zeng | Medigen Vaccine Biologics | N/A | |
Longye Zhuo | TaiMed Biologics | N/A | |
Qiuxiong Lin | Adimmune Corp | N/A | |
MingChing Chen | TaiMed Biologics | N/A | |
Fengyi Feng | Oneness Biotech Co | N/A | |
Ruiwen Huang | Oneness Biotech Co | N/A | |
Yunpeng Zhu | Adimmune Corp | N/A | |
Jianfu Chen | Adimmune Corp | N/A | |
Yushu Lin | Adimmune Corp | N/A | |
Wenmei Fu | Adimmune Corp | N/A | |
Chaoquan Ou | Medigen Vaccine Biologics | N/A | |
Bill Ou | Medigen Vaccine Biologics | N/A | |
TayChang Wang | TaiMed Biologics | N/A | |
Zhongxian Liu | TaiMed Biologics | N/A | |
Jiazhen Zhu | Adimmune Corp | N/A | |
Yaoji Li | Medigen Vaccine Biologics | N/A | |
Jianxin Zheng | Adimmune Corp | N/A | |
Zhihui Zheng | Oneness Biotech Co | N/A | |
Luping Zhou | TaiMed Biologics | N/A |
Management Performance
Return On Equity | 0.0985 | |||
Return On Asset | 0.0589 |
PharmaEngine Leadership Team
Elected by the shareholders, the PharmaEngine's board of directors comprises two types of representatives: PharmaEngine inside directors who are chosen from within the company, and outside directors, selected externally and held independent of PharmaEngine. The board's role is to monitor PharmaEngine's management team and ensure that shareholders' interests are well served. PharmaEngine's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, PharmaEngine's outside directors are responsible for providing unbiased perspectives on the board's policies.
Xiuji Zhang, Director | ||
Lin C, Director | ||
PoWu Gean, Director | ||
Changjing Ye, CEO, General Manager, Director | ||
HongRen Wang, Pres CEO | ||
Yusheng Zhao, Director | ||
LiSheng Chu, Independent Director | ||
Fuxiu Yin, Independent Director | ||
Guocai Pan, Director | ||
Yuqing Su, Independent Director | ||
ChiHsing Chang, VP Devel | ||
Kunhong Lai, Independent Director | ||
Chuan Lin, Director | ||
YuFang Hu, General Manager | ||
Bowu Jian, Director | ||
Qiying Huang, Director | ||
Jinrong Lin, Director | ||
Jeffrey Suen, Chairman of the Board | ||
Peter Wu, Director Sales | ||
Junhui He, Chairman of the Board | ||
Quan Lin, Director | ||
Zhili Wang, Independent Director | ||
C Chang, Deputy General Manager-Finance & Administration | ||
Kangji Zhou, Independent Director | ||
Hubert Chan, Deputy General Manager-Clinical & Regulatory Affairs | ||
KangChi Chou, Independent Director | ||
Melody Lin, Director HR | ||
Lizhen Lin, Director | ||
Li Lin, Director | ||
Qixing Zhang, Senior Head-Finance and Administration Management | ||
WenHwa Chang, Director | ||
Ruiwen Wu, Director | ||
Yihui Lin, Director | ||
Jose Hsieh, Sr Accounting | ||
Zhaosheng Wu, Deputy Head of Development Department | ||
FuShiow Yin, Independent Director | ||
Huai Wang, Independent Director | ||
Grace Yeh, CEO, General Manager, Director | ||
Qixiang Chen, Director | ||
MingThau Sheu, Director | ||
Xinyi Lin, Director |
PharmaEngine Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is PharmaEngine a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.0985 | |||
Return On Asset | 0.0589 | |||
Profit Margin | 0.54 % | |||
Operating Margin | 0.53 % | |||
Current Valuation | 14.42 B | |||
Shares Outstanding | 143.69 M | |||
Shares Owned By Insiders | 22.57 % | |||
Shares Owned By Institutions | 20.72 % | |||
Price To Book | 4.72 X | |||
Price To Sales | 24.13 X |
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in PharmaEngine. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Complementary Tools for PharmaEngine Stock analysis
When running PharmaEngine's price analysis, check to measure PharmaEngine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PharmaEngine is operating at the current time. Most of PharmaEngine's value examination focuses on studying past and present price action to predict the probability of PharmaEngine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PharmaEngine's price. Additionally, you may evaluate how the addition of PharmaEngine to your portfolios can decrease your overall portfolio volatility.
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Stocks Directory Find actively traded stocks across global markets | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |